TLR2 and neoplasm: Although the precise mechanisms by which TLR2 modulates DC subset functionality, particularly tumor-infiltrating cDC1s, remain incompletely resolved [36, 37], we demonstrated that SUP3 slows endosomal acidification in cDC1s, delaying antigen degradation and thereby facilitating cross-presentation.